$Delta Air Lines (DAL.US)$+2% (The airline projected "record advance bookings for the summer." It expects sales in the current quarter to increase by 15% to 17% over last year, topping Refinitiv estimates of 14.7%. Delta forecasted adjusted earnings per share of between $2 and $2.25, versus the $1.66 expected by analysts.)
$Merck & Co (MRK.US)$+1% (The company wasupgraded by Citi to buy from neutral, saying its drug pipeline is underappreciated. The Wall Street firm boosted the stock's price target to $130, which implies 14% upside from Wednesday's closing price.)
$NOVO NORDISK A/S (NONOF.US)$+2% (The maker of diabetes and weight loss drugs Ozempic and Wegovy moved about 2% higher in the premarket after being upgraded by Credit Suisse to outperform from neutral. The Wall Street firm said growth in the drugs has "significantly outperformed" its expectations.)
$Harley-Davidson (HOG.US)$-4% (UBS said retail declines for the motorcycle maker in the first quarter may be worse than expected. The Wall Street firm said retail sales could be down close to 20% at U.S. dealers.)
Source: Dow Jones, CNBC
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.